antithrombin

n.  抗凝血酶

医学化学



双语例句

  1. Antithrombin III, Sheep anti-Rabbit; paraffin.
    抗凝血酶III,绵羊抗兔;石蜡切片。
  2. Denaturing high-performance liquid chromatography for screening antithrombin ⅲ gene mutation and polymorphisms in patients with cerebral venous thrombosis
    应用变性高效液相色谱筛查颅内静脉系统血栓形成AT-Ⅲ基因突变及多态性
  3. The Detection of Plasma of Platelet Aggregation, Antithrombin and D-dimmer Fibrinogen in Acute Cerebral Infarction Patient
    急性脑梗死患者抗凝血酶Ⅲ、D-二聚体、血小板聚集和纤维蛋白原的测定
  4. Researchers have used the interaction between a polysaccharide called heparin and a peptide fragment of a protein called antithrombin III, which is contained in the bloodstream to control clotting.
    研究者利用了肝素(一种多糖)和血液中的抗凝血酶III(一种多肽片断)之间的相互作用来控制凝固时间。
  5. The researchers attached heparin-binding peptides from antithrombin III to a synthetic material called polyethylene glycol.
    研究人员将抗凝血酶III上的肝素结合肽段黏附在称为聚乙二醇的人工合成材料上。
  6. Study on Relationship between Antithrombin Gene Polymorphisms and Susceptibility to Pulmonary Thromboembolism in Han People in Shanghai
    上海地区汉族人群抗凝血酶基因多态性与肺血栓栓塞症易感性的研究
  7. The Research of the cDNA Clone, Expression& Purification of Human Antithrombin ⅲ and the Therapeutic Effect of Its Recombinant Protein on DIC Rat Model
    人抗凝血酶Ⅲ的cDNA克隆、表达、纯化及其重组蛋白对DIC大鼠模型的疗效研究
  8. Significance of measurement of D-dimer concentration and antithrombin-ⅲ in lung cancer
    肺癌D-二聚体定量与抗凝血酶Ⅲ活性测定的意义
  9. Effect of exercise on antithrombin III and adhesive proteins in aged diabetic Patients
    运动对老年糖尿病人抗凝血酶Ⅲ及粘附蛋白的影响
  10. Factor V gene, prothrombin gene and tissue factor gene in clotting system, thrombomodulin gene and antithrombin III in anti clotting system, plasminogen activator inhibitor 1 gene in fibrinolytic system, are related with hypercoagulability tightly.
    凝血系统的凝血因子Ⅴ基因、凝血酶原基因、组织因子基因,抗凝系统的血栓调节蛋白基因、抗凝血酶Ⅲ基因,纤溶系统的纤溶酶原激活物抑制剂1基因,均与高血凝密切相关。
  11. Changes in Protein C and Antithrombin ⅲ during Warfarin Anticoagulation
    口服华法令抗凝中蛋白C和抗凝血酶Ⅲ的变化
  12. Objective To identify the gene mutation of a kindred with type ⅰ antithrombin deficiency.
    目的对一先天性Ⅰ型抗凝血酶缺乏症家系进行基因突变的检测。
  13. Antithrombin ( AT) can inhibit the activity of thrombin.
    抗凝血酶(AT)能抑制凝血酶的活性,AT缺乏或低下可引起凝血酶灭活减少,凝血功能亢进。
  14. A Study on Preparation and Clinical Application of Antithrombin ⅲ Concentrate ⅰ. Isolation and Purification of Antithrombin ⅲ
    抗凝血酶Ⅲ浓缩物制备及临床应用的研究一、抗凝血酶Ⅲ的分离与纯化
  15. Conclusion: The rats with hemorrhagic shock have trauma of endothelial cells and decrease of protein C and antithrombin due to consumption.
    结论:失血性休克可导致大鼠内皮细胞损伤,抗凝血酶和蛋白C呈消耗性下降;
  16. Conclusion This is a novel mutation, which can cause antithrombin deficiency and thrombosis.
    结论该突变是先天性抗凝血酶缺乏症的一个新的突变位点,可以导致血栓形成。
  17. The study of the serum factor ⅱ and antithrombin activity in the patients with hepatocirrhosis
    肝硬化患者血浆凝血因子Ⅱ活性与抗凝血酶的研究
  18. In our study, a multifunctional hybrid molecule expressing antiplatelet and antithrombin simultaneously was produced using genetic engineering, and the activation of antiplatelet and antithrombin was assessed in vitro.
    本实验通过基因工程的方法,人工合成一种能同时表达抗血小板和抗凝血酶的多功能杂交分子,并在体外实验中观察其抗血小板和抗凝血酶的活性,为抗栓药物的研制提供一个新的方向。
  19. Study on Changes in Protein C System and Antithrombin ⅲ in Patients with Systemic Lupus Erythematosus
    系统性红斑狼疮患者蛋白C系统及抗凝血酶Ⅲ变化的研究
  20. The Comparative Observation of Plasma Protein C and Antithrombin ⅲ Levels in Hepatic Cirrhosis and Diabetes Mellitus
    肝硬化和糖尿病病人血浆蛋白C和抗凝血酶Ⅲ的测定
  21. The research process of Antithrombin ⅲ, its existence and content, molecular structure, physicochemical characteristics, gene expression and genetic deficiency have been presented in the article.
    介绍了抗凝血酶Ⅲ的研究过程,其存在与含量、分子结构、理化特性、基因表达及遗传缺陷等。
  22. Conclusion: Sjamp was similar to dermatan sulfate both in the efficiency and in the mechanism of antithrombin.
    结论:在抗凝血酶作用方面,Sjamp的效率(K2值)及机制(HCⅡ依赖性)与硫酸皮肤素类似。
  23. Effects of methionine-induced hyperhomocysteinemia on protein C, antithrombin-ⅲ and von willebrand factor
    高甲硫氨酸诱发高同型半胱氨酸血症对抗凝血酶-Ⅲ,蛋白C和血管性血友病因子的影响
  24. The Mensuration and Analysis of Tissue Factor Pathway Inhibitor and Antithrombin-ⅲ in Acute Viral Hepatitis
    组织因子途径抑制物与抗凝血酶Ⅲ在急性病毒性肝炎患者中的测定与分析
  25. Objective To improve the bioactivity of antithrombin ⅲ( AT-ⅲ) significantly by DNA shuffling.
    目的利用DNA改组技术大幅度提高抗凝血酶Ⅲ(AT-Ⅲ)的生物活性。
  26. Study and Clinical Significance of antithrombin ⅲ, Plasminogen and D-Dimer
    抗凝血酶III,纤溶酶原及D-二聚体的研究及临床意义
  27. A biomaterial silk fibroin is surface modified using antithrombin-ⅲ( AT-ⅲ) to improve its anticoagulant property.
    用抗凝血酶(antithrombin-,AT-)和肝素对生物材料进行表面改性,以提高其抗凝血性能。
  28. Objective To investigate the diagnostic significance of detection of antithrombin activity in DIC.
    目的探讨抗凝血酶活性(AT:A)检测在诊断弥散性血管内凝血(DIC)中的意义。
  29. Antithrombin activity was significantly decreased ( P < 0.001).
    抗凝血酶活力显著降低(P<0.001)。
  30. Antithrombin ⅲ partly balanced the hypercoagulable state.
    抗凝血酶活性增强部分平衡了高凝倾向。